STOCKHOLDERS' EQUITY - Schedule of Information Related to Stock Options (Details) - Stock Options |
12 Months Ended |
---|---|
Dec. 31, 2022
$ / shares
shares
| |
STOCKHOLDERS' EQUITY | |
Options Outstanding, Weighted Outstanding Number of Options | 36,667 |
Options Exercisable, Average Remaining Life In Years | 7 years 4 months 24 days |
Options Exercisable, Exercisable Number of Options | 22,892 |
Exercise Price $2.81 | |
STOCKHOLDERS' EQUITY | |
Options Outstanding, Exercise price | $ / shares | $ 2.81 |
Options Outstanding, Weighted Outstanding Number of Options | 20,000 |
Options Exercisable, Average Remaining Life In Years | 7 years 10 months 24 days |
Options Exercisable, Exercisable Number of Options | 10,400 |
Exercise Price $2.97 | |
STOCKHOLDERS' EQUITY | |
Options Outstanding, Exercise price | $ / shares | $ 33.75 |
Options Outstanding, Weighted Outstanding Number of Options | 16,667 |
Options Exercisable, Average Remaining Life In Years | 7 years |
Options Exercisable, Exercisable Number of Options | 12,492 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|